Treatment of tobacco use in lung cancer: Diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines

Chest

Volumn 143, Issue 5 SUPPL, 2013, Pages

  Leone, Frank T ^a   Evers Casey, Sarah ^a   Toll, Benjamin A ^b   Vachani, Anil ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTINEOPLASTIC AGENT; CLONIDINE; CYCLIC AMP; NICOTINE; NICOTINE GUM; NICOTINE LOZENGE; NICOTINE PATCH; NICOTINIC RECEPTOR; NORTRIPTYLINE; PAROXETINE; PLACEBO; TRANSCRIPTION FACTOR FOSB; VARENICLINE; VENLAFAXINE;

ARTICLE; BONE NECROSIS; BRONCHUS MUCUS; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CINAHL; CLINICAL PRACTICE; COCHRANE LIBRARY; COGNITIVE THERAPY; COMPUTER ASSISTED TOMOGRAPHY; DEPRESSION; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG MEGADOSE; EMBASE; EVIDENCE BASED MEDICINE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HEALTH CARE POLICY; HUMAN; LUNG CANCER; LUNG COMPLICATION; LUNG RESECTION; MEDICAL ETHICS; MEDICAL SPECIALIST; MEDLINE; MONOTHERAPY; NICOTINE REPLACEMENT THERAPY; PATIENT ATTITUDE; PATIENT CARE; PATIENT COUNSELING; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PSYCINFO; QUALITY OF LIFE; RELAPSE; SELF HELP; SMOKING CESSATION; SURGICAL RISK; SYSTEMATIC REVIEW; TOBACCO DEPENDENCE; TREATMENT REFUSAL; VENTRAL TEGMENTUM;

EID: 84877638767     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-2349     Document Type: Article

References (71)

1. Lewis SZ, Diekemper R, Addrizzo-Harris DJ. Methodology for development of guidelines for lung cancer: d iagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013; 143 (5)(suppl): 41S-50S.
2. Leone FT, Evers-Casey S. Developing a rational approach to tobacco use treatment in pulmonary practice: a review of the biological basis of nicotine addiction. Clin Pulm Med. 2012; 19 (2): 53-61.
3. Schnoll RA, Rothman RL, Newman H, et al. Characteristics of cancer patients entering a smoking cessation program and correlates of quit motivation: implications for the development of tobacco control programs for cancer patients. Psychooncology. 2004; 13 (5): 346-358.
4. Ahuja R, Weibel SB, Leone FT. Lung cancer: the oncologist's role in smoking cessation. Semin Oncol. 2003; 30 (1): 94-103.
5. Alcaro A, Huber R, Panksepp J. Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective. Brain Res Brain Res Rev. 2007; 56 (2): 283-321.
6. Mansvelder HD, Keath JR, McGehee DS. Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron. 2002; 33 (6): 905-919.
7. Azam L, Winzer-Serhan UH, Chen Y, Leslie FM. Expression of neuronal nicotinic acetylcholine receptor subunit mRNAs within midbrain dopamine neurons. J Comp Neurol. 2002; 444 (3): 260-274.
8. Henningfield JE. Behavioral pharmacology of cigarette smoking. In: Thompson T, Dews PB, Barrett J, eds. Advances in Behavioral Pharmacology. Vol 4. New York, NY: Academic Press; 1984 : 131-210.
9. Aguilar MA, Rodríguez-Arias M, Miñarro J. Neurobiological mechanisms of the reinstatement of drug-conditioned place preference. Brain Res Brain Res Rev. 2009; 59 (2): 253-277.
10. Pascual MM, Pastor V, Bernabeu RO. Nicotine-conditioned place preference induced CREB phosphorylation and Fos expression in the adult rat brain. Psychopharmacology (Berl). 2009; 207 (1): 57-71.
11. Centers for Disease Control and Prevention (CDC). Statespecific prevalence and trends in adult cigarette smoking-United States, 1998-2007. MMWR Morb Mortal Wkly Rep. 2009; 58 (9): 221-226.
12. Levy DT, Mumford EA, Gerlowski DA. Examining trends in quantity smoked. Nicotine Tob Res. 2007; 9 (12): 1287-1296.
13. Ending the tobacco problem : a blueprint for the nation. Institute of Medicine website. http://www.iom.edu/Reports/2007/Ending-the-Tobacco-Problem-A- Blueprint-for-the-Nation.aspx. Accessed March 4, 2013.
14. Nonnemaker J, Hersey J, Homsi G, et al. Self-reported exposure to policy and environmental influences on smoking cessation and relapse: a 2-year longitudinal populationbased study. Int J Environ Res Public Health. 2011; 8 (9): 3591-3608.
15. Jemal A, Thun MJ, Ries LAG, et al. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst. 2008; 100 (23): 1672-1694.
16. Cox LS, Africano NL, Tercyak KP, Taylor KL. Nicotine dependence treatment for patients with cancer. Cancer. 2003; 98 (3): 632-644.
17. Cataldo JK, Dubey S, Prochaska JJ. Smoking cessation: an integral part of lung cancer treatment. Oncology. 2010; 78(5-6): 289-301.
18. Parsons A, Daley A, Begh R, Aveyard P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with metaanalysis. BMJ. 2010; 340 : b5569.
19. Trousse D, Barlesi F, Loundou A, et al. Synchronous multiple primary lung cancer: an increasing clinical occurrence requiring multidisciplinary management. J Thorac Cardiovasc Surg. 2007; 133 (5): 1193-1200.
20. Tucker MA, Murray N, Shaw EG, et al. Second primary cancers related to smoking and treatment of small-cell lung cancer. Lung Cancer Working Cadre. J Natl Cancer Inst. 1997; 89 (23): 1782-1788.
21. Rice D, Kim HW, Sabichi A, et al. The risk of second primary tumors after resection of stage I nonsmall cell lung cancer. Ann Thorac Surg. 2003; 76(4):1001-1007.
22. Johnson BE. Second lung cancers in patients after treatment for an initial lung cancer. J Natl Cancer Inst. 1998; 90 (18): 1335-1345.
23. Schnoll RA, Rothman RL, Lerman C, et al. Comparing cancer patients who enroll in a smoking cessation program at a comprehensive cancer center with those who decline enrollment. Head Neck. 2004; 26 (3): 278-286.
24. Schnoll RA, Malstrom M, James C, et al. Correlates of tobacco use among smokers and recent quitters diagnosed with cancer. Patient Educ Couns. 2002; 46 (2): 137-145.
25. Fiore MC, Jaén CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD : US Department of Health and Human Services. Public Health Service; 2008.
26. Gritz ER, Fingeret MC, Vidrine DJ, et al. Successes and failures of the teachable moment. Cancer. 2006; 106(1):17-27.
27. Leone FT, Evers-Casey S. Behavioral interventions in tobacco dependence. Prim Care. 2009; 36 (3): 489-507.
28. Carpenter MJ, Hughes JR, Gray KM, Wahlquist AE, Saladin ME, Alberg AJ. Nicotine therapy sampling to induce quit attempts among smokers unmotivated to quit: a randomized clinical trial. Arch Intern Med. 2011; 171 (21): 1901-1907.
29. Lindson N, Aveyard P. An updated meta-analysis of nico tine preloading for smoking cessation: investigating mediators of the effect. Psychopharmacology (Berl). 2011; 214 (3): 579-592.
30. Hajek P, McRobbie HJ, Myers KE, Stapleton J, Dhanji AR. Use of varenicline for 4 weeks before quitting smoking: decrease in ad lib smoking and increase in smoking cessation rates. Arch Intern Med. 2011; 171 (8): 770-777.
31. Sachs DPL, Leone FT, Farber HJ, et al. ACCP Tobacco Dependence Treatment Toolkit. American College of Chest Physicians website. http://tobaccodependence. chestnet.org. Acessed March 4, 2013.
32. Schnoll RA, Miller SM, Unger M, McAleer C, Halbherr T, Bradley P. Characteristics of female smokers attending a lung cancer screening program: a pilot study with implications for program development. Lung Cancer. 2002; 37 (3): 257-265.
33. Cox LS, Clark MM, Jett JR, et al. Change in smoking status after spiral chest computed tomography scan screening. Cancer. 2003; 98 (11): 2495-2501.
34. Clark MM, Cox LS, Jett JR, et al. Effectiveness of smoking cessation self-help materials in a lung cancer screening population. Lung Cancer. 2004; 44 (1): 13-21.
35. Ashraf H, Tønnesen P, Holst Pedersen J, Dirksen A, Thorsen H, Døssing M. Effect of CT screening on smoking habits at 1-year follow-up in the Danish Lung Cancer Screening Trial (DLCST). Thorax. 2009; 64 (5): 388-392.
36. Styn MA, Land SR, Perkins KA, Wilson DO, Romkes M, Weissfeld JL. Smoking behavior 1 year after computed tomography screening for lung cancer: effect of physician referral for abnormal CT findings. Cancer Epidemiol Biomarkers Prev. 2009; 18 (12): 3484-3489.
37. Anderson CM, Yip R, Henschke CI, et al. Smoking cessation and relapse during a lung cancer screening program. Cancer Epidemiol Biomarkers Prev. 2009; 18 (12): 3476-3483.
38. MacRedmond R, McVey G, Lee M, et al. Screening for lung cancer using low dose CT scanning: results of 2 year follow up. Thorax. 2006; 61 (1): 54-56.
39. van der Aalst CM, de Koning HJ, van den Bergh KAM, Willemsen MC, van Klaveren RJ. The effectiveness of a computer-tailored smoking cessation intervention for participants in lung cancer screening: a randomised controlled trial. Lung Cancer. 2012; 76 (2): 204-210.
40. Parkes G, Greenhalgh T, Griffin M, Dent R. Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial. BMJ. 2008; 336 (7644): 598-600.
41. Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE; Lung Health Study Research Group. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med. 2005; 142 (4): 233-239.
42. Osinubi OYO, Moline J, Rovner E, et al. A pilot study of telephone-based smoking cessation intervention in asbestos workers. J Occup Environ Med. 2003; 45(5):569-574.
43. Thomsen T, Villebro N, Møller AM. Interventions for preoperative smoking cessation. Cochrane Database Syst Rev. 2010; (7):CD002294.
44. Mason DP, Subramanian S, Nowicki ER, et al. Impact of smoking cessation before resection of lung cancer: a Society of Thoracic Surgeons General Thoracic Surgery Database study. Ann Thorac Surg. 2009; 88(2):362-370.
45. Barrera R, Shi W, Amar D, et al. Smoking and timing of cessation: impact on pulmonary complications after thoracotomy. Chest. 2005; 127 (6): 1977-1983.
46. Nakagawa M, Tanaka H, Tsukuma H, Kishi Y. Relationship between the duration of the preoperative smoke-free period and the incidence of postoperative pulmonary complications after pulmonary surgery. Chest. 2001; 120 (3): 705-710.
47. Vaporciyan AA, Merriman KW, Ece F, et al. Incidence of major pulmonary morbidity after pneumonectomy: association with timing of smoking cessation. Ann Thorac Surg. 2002; 73(2):420-425.
48. Groth SS, Whitson BA, Kuskowski MA, Holmstrom AM, Rubins JB, Kelly RF. Impact of preoperative smoking status on postoperative complication rates and pulmonary function test results 1-year following pulmonary resection for nonsmall cell lung cancer. Lung Cancer. 2009; 64 (3): 352-357.
49. Stanislaw AE, Wewers ME. A smoking cessation intervention with hospitalized surgical cancer patients: a pilot study. Cancer Nurs. 1994; 17 (2): 81-86.
50. Wewers ME, Bowen JM, Stanislaw AE, Desimone VB. A nursedelivered smoking cessation intervention among hospitalized postoperative patients-influence of a smoking-related diagnosis: a pilot study. Heart Lung. 1994; 23 (2): 151-156.
51. Griebel B, Wewers ME, Baker CA. The effectiveness of a nurse-managed minimal smoking-cessation intervention among hospitalized patients with cancer. Oncol Nurs Forum. 1998; 25 (5): 897-902.
52. Browning KK, Ahijevych KL, Ross P Jr, Wewers ME. Implementing the Agency for Health Care Policy and Research's Smoking Cessation Guideline in a lung cancer surgery clinic. Oncol Nurs Forum. 2000; 27 (8): 1248-1254.
53. Dresler CM, Bailey M, Roper CR, Patterson GA, Cooper JD. Smoking cessation and lung cancer resection. Chest. 1996; 110 (5): 1199-1202.
54. Wewers ME, Jenkins L, Mignery T. A nurse-managed smoking cessation intervention during diagnostic testing for lung cancer. Oncol Nurs Forum. 1997; 24 (8): 1419-1422.
55. Thomsen T, Tønnesen H, Okholm M, et al. Brief smoking cessation intervention in relation to breast cancer surgery: a randomized controlled trial. Nicotine Tob Res. 2010; 12 (11): 1118-1124.
56. Park ER, Japuntich S, Temel J, et al. A smoking cessation intervention for thoracic surgery and oncology clinics: a pilot trial. J Thorac Oncol. 2011; 6 (6): 1059-1065.
57. Kozower BD, Lau CL, Phillips JV, et al. A thoracic surgeondirected tobacco cessation intervention. Ann Thorac Surg. 2010; 89(3):926-930.
58. Thomsen T, Esbensen BA, Samuelsen S, Tønnesen H, Møller AM. Brief preoperative smoking cessation counselling in relation to breast cancer surgery: a qualitative study. Eur J Oncol Nurs. 2009; 13 (5): 344-349.
59. Wakefield M, Olver I, Whitford H, Rosenfeld E. Motivational interviewing as a smoking cessation intervention for patients with cancer: randomized controlled trial. Nurs Res. 2004; 53 (6): 396-405.
60. Schnoll RA, Rothman RL, Wielt DB, et al. A randomized pilot study of cognitive-behavioral therapy versus basic health education for smoking cessation among cancer patients. Ann Behav Med. 2005; 30(1):1-11.
61. de Bruin-Visser JC, Ackerstaff AH, Rehorst H, et al. Integration of a smoking cessation program in the treatment protocol for patients with head and neck and lung cancer. Eur Arch Otorhinolaryngol. 2012; 269 (2): 659-665.
62. Gritz ER, Carr CR, Rapkin D, et al. Predictors of long-term smoking cessation in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev. 1993; 2 (3): 261-270.
63. Duffy SA, Ronis DL, Valenstein M, et al. A tailored smoking, alcohol, and depression intervention for head and neck cancer patients. Cancer Epidemiol Biomarkers Prev. 2006; 15 (11): 2203-2208.
64. Schnoll RA, Zhang B, Rue M, et al. Brief physician-initiated quit-smoking strategies for clinical oncology settings: a trial coordinated by the Eastern Cooperative Oncology Group. J Clin Oncol. 2003; 21 (2): 355-365.
65. Schnoll RA, Martinez E, Tatum KL, et al. A bupropion smoking cessation clinical trial for cancer patients. Cancer Causes Control. 2010; 21 (6): 811-820.
66. Sanderson Cox L, Patten CA, Ebbert JO, et al. Tobacco use outcomes among patients with lung cancer treated for nicotine dependence. J Clin Oncol. 2002; 20 (16): 3461-3469.
67. Garces YI, Schroeder DR, Nirelli LM, et al. Tobacco use outcomes among patients with head and neck carcinoma treated for nicotine dependence: a matched-pair analysis. Cancer. 2004; 101 (1): 116-124.
68. Zevallos JP, Mallen MJ, Lam CY, et al. Complications of radiotherapy in laryngopharyngeal cancer: effects of a prospective smoking cessation program. Cancer. 2009; 115 (19): 4636-4644.
69. Semrau S, Klautke G, Virchow JC, Kundt G, Fietkau R. Impact of comorbidity and age on the outcome of patients with inoperable NSCLC treated with concurrent chemoradiotherapy. Respir Med. 2008; 102 (2): 210-218.
70. Slatore CG, Au DH, Hollingworth W. Cost-effectiveness of a smoking cessation program implemented at the time of surgery for lung cancer. J Thorac Oncol. 2009; 4 (4): 499-504.
71. Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan GE. Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res. 2003; 5 (1): 13-25.